147 related articles for article (PubMed ID: 37863634)
1. The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy.
Beck LH
Kidney Int; 2023 Nov; 104(5):878-880. PubMed ID: 37863634
[TBL] [Abstract][Full Text] [Related]
2. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients.
Meyer-Schwesinger C; Tomas NM; Dehde S; Seifert L; Hermans-Borgmeyer I; Wiech T; Koch-Nolte F; Huber TB; Zahner G
Kidney Int; 2020 May; 97(5):913-919. PubMed ID: 32033781
[TBL] [Abstract][Full Text] [Related]
3. Toward a bona fide animal model of PLA2R1-associated membranous nephropathy: one step forward.
Bihl F; Lambeau G
Kidney Int; 2023 Feb; 103(2):251-253. PubMed ID: 36681452
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
5. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
6. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
8. [Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B; Lambeau G; Esnault V
Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of the development and course of membranous nephropathy.
Kamyshova ES; Bobkova IN; Gorelova IA; Каkhsurueva PA; Filatova EE
Ter Arkh; 2018 Jun; 90(6):105-111. PubMed ID: 30701913
[TBL] [Abstract][Full Text] [Related]
10. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
11. Glomerular disease: thrombospondin type-1 domain-containing 7A-a new player in membranous nephropathy.
Allison SJ
Nat Rev Nephrol; 2015 Feb; 11(2):63. PubMed ID: 25447129
[No Abstract] [Full Text] [Related]
12. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Gödel M; Grahammer F; Huber TB
N Engl J Med; 2015 Mar; 372(11):1073. PubMed ID: 25760365
[No Abstract] [Full Text] [Related]
13. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Meyer-Schwesinger C; Lambeau G; Stahl RA
N Engl J Med; 2015 Mar; 372(11):1074-5. PubMed ID: 25760364
[No Abstract] [Full Text] [Related]
14. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
15. Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy.
Tomas NM; Schnarre A; Dehde S; Lucas R; Hermans-Borgmeyer I; Kretz O; Koellner SMS; Wiech T; Koch-Nolte F; Seifert L; Huber TB; Zahner G
Kidney Int; 2023 Nov; 104(5):916-928. PubMed ID: 37598854
[TBL] [Abstract][Full Text] [Related]
16. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
Stahl RAK; Hoxha E
Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275
[TBL] [Abstract][Full Text] [Related]
17. Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.
Tomas NM; Dehde S; Meyer-Schwesinger C; Huang M; Hermans-Borgmeyer I; Maybaum J; Lucas R; von der Heide JL; Kretz O; Köllner SMS; Seifert L; Huber TB; Zahner G
Kidney Int; 2023 Feb; 103(2):297-303. PubMed ID: 36191868
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin type-1 domain-containing 7A-related membranous nephropathy associated with glomerular AL amyloidosis.
Morel A; Buob D; Goujon JM; Belhadj K; Verpont MC; Audard V; Moktefi A
Pathology; 2022 Aug; 54(5):654-657. PubMed ID: 34774302
[No Abstract] [Full Text] [Related]
19. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
[TBL] [Abstract][Full Text] [Related]
20. Clinical Relevance of Domain-Specific Phospholipase A
Reinhard L; Zahner G; Menzel S; Koch-Nolte F; Stahl RAK; Hoxha E
J Am Soc Nephrol; 2020 Jan; 31(1):197-207. PubMed ID: 31843985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
